|
中文别名
|
替加环素;(4S,4aS,5aR,12aS)-4,7-双(二甲氨基)-9-[(叔丁基氨基)乙酰胺基]-3,10,12,12a-四羟基-1,11-二氧代-1,4,4a,5,5a,6,11,12a-八氢并四苯-2-甲酰胺;枸缘酸苯海拉明;替加环素 USP标准品;替加环素及其中间体;2-并四苯甲酰胺,4,7-双(二甲胺基)-9-[[2-[(1,1-二甲基乙基)氨基]乙酰基]氨基]-1,4,4A,5,5A,6,11,12A-八氢-3,10,12,12A-四羟基-1,11-二氧代-,(4S,4AS,5AR,12AS);9-叔丁基甘氨酰氨基米诺环素;替加环素(对照品) |
| 英文别名 |
Tigecycline;2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-[[[(1,1-DIMETHYLETHYL)AMINO]ACETYL]AMINO]-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-;(4s,4as,5ar,12as)-4,7-bis(dimethylamino)-9-[(tert-butylamino)acetamido]-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-carboxamide;TIGECYCLINE GLYCYLCYCLINE;(4S,4As,5aR,12as)-4,7-Bis(dimethylamino)-9-{(tert-butylamino)acetamido}-3,10,12,12a-octahydrotetracen-2-carboxamide;(4S,4AS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxa;GAR-936;2-NAPHTHACENECARBOXAMIDE;9-t-Butylglycylamido-minocycline hydrate;Glycylcycline;Tegecycline;TIGECYCLINE POWDER;Tigercycline;Tygacil;WAY-GAR 936;9-tert-Butylglycylamidominocycline;TBG-MINO;GAR 936;70JE2N95KR;Tigecyclin;Tigecycline hydrate;NSC-794945;(4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1;CS-1876;GTPL10929;TIGECYCLINE [JAN];Tigecycline (JAN/USP);UNII-70JE2N95KR;SCHEMBL101795;TIGECYCLINE [WHO-DD];NS00011897;NCGC00183095-01;AS-30703;SCHEMBL237962;WAY-GAR-936;SMR002530064;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;TIGECYCLINE [INN];AC-1798;TIGECYCLINE [EMA EPAR];s1403;DTXSID2048581;(4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide;GAR-936,Tigecycline;TIGECYCLINE [USP-RS];220620-09-7 (anhy.);(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide;AKOS025401452;9-t-butylglycylamido-minocycline;CAS-220620-09-7;TIGECYCLINE [USP MONOGRAPH];Tygacil (TN);(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide;Q-101396;Tigilcycline;SCHEMBL105082;2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;TIGECYCLINE [EP MONOGRAPH];(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide;BCPP000045;Tox21_112910;BDBM50247905;TIGECYCLINE [VANDF];2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-;Tigecycline 95%;AB01566818_01;FPZLLRFZJZRHSY-HJYUBDRYSA-N;D01079;Tigecycline [USAN:INN:BAN];DB00560;NSC794945;Tigecycline, Antibiotic... |
